HomeVERV • NASDAQ
add
Verve Therapeutics Inc
Nakaraang pagsara
$5.50
Sakop ng taon
$2.86 - $9.31
Market cap
490.29M USD
Average na Volume
4.19M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 13.08M | 154.28% |
Gastos sa pagpapatakbo | 195.60M | 9.82% |
Net na kita | -50.04M | -3.48% |
Net profit margin | -382.53 | 59.30% |
Kita sa bawat share | -0.58 | 15.94% |
EBITDA | -54.37M | -3.69% |
Aktuwal na % ng binabayarang buwis | -0.15% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 524.28M | -15.97% |
Kabuuang asset | 647.39M | -13.99% |
Kabuuang sagutin | 153.99M | 0.53% |
Kabuuang equity | 493.40M | — |
Natitirang share | 88.80M | — |
Presyo para makapag-book | 0.99 | — |
Return on assets | -21.38% | — |
Return on capital | -24.52% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -50.04M | -3.48% |
Cash mula sa mga operasyon | -40.84M | -0.41% |
Cash mula sa pag-invest | 29.55M | 432.24% |
Cash mula sa financing | 25.15M | -85.82% |
Net change in cash | 13.85M | -89.16% |
Malayang cash flow | -26.02M | -9.60% |
Tungkol
Itinatag
2018
Headquarters
Website
Mga Empleyado
274
